Who is sponsoring NCT03683485?

NCT03683485 is sponsored by Dankook University.

What drugs are being tested in NCT03683485?

Interventions in NCT03683485: long duration EPBD, EST.

What condition does NCT03683485 study?

NCT03683485 studies Cholangiopancreatography, Endoscopic Retrograde.

Is NCT03683485 still recruiting?

NCT03683485 is currently status unknown. Last updated 1 October 2018.

Last reviewed 2018-10-01 · How we verify

NCT03683485

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Long-duration EPBD vs EST for Removal of Biliary Stones

Status unknown NA Last updated 1 October 2018

What this trial tests

NA trial testing long duration EPBD in Cholangiopancreatography, Endoscopic Retrograde in 358 participants. Status unknown.

Timeline

1 April 2018

Primary endpoint
1 May 2019

1 August 2021

Quick facts

Lead sponsor	Dankook University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	358
Start date	1 April 2018
Primary completion	1 May 2019
Estimated completion	1 August 2021
Sites	4 locations across South Korea

Drugs / interventions tested

long duration EPBD
EST

Conditions studied

Cholangiopancreatography, Endoscopic Retrograde — all drugs for Cholangiopancreatography, Endoscopic Retrograde →

Sponsor

Dankook University

Who can join

18 and older, any sex, with Cholangiopancreatography, Endoscopic Retrograde. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Although EPBD has a lower risk of post-ERCP bleeding and long-term complications than EST and is easier to perform in altered/difficult anatomy, EPBD is reserved for patients with bleeding diathesis by current consensus because some studies reported a higher risk of pancreatitis. However, recent meta-analyses indicate that short EPBD duration increases the risk of post-ERCP pancreatitis, and EPBD with adequate duration has a similar pancreatitis risk and a lower overall complication rate compared with EST for choledocholithiasis. Therefore, this study aim to compare long-duration EPBD vs EST in the treatment of extrahepatic biliary stones.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Cholangiopancreatography, Endoscopic Retrograde

Currently open trials in the same condition.

NCT07211828 — EEG and Pain Monitor Data Under Anesthesia to Study Pharmacodynamic Effects of Opioids and Sedatives · NA · recruiting
NCT05246657 — EUS-guided Entero-biliary Anastomosis for Therapeutic Access in Benign Biliary Obstructions · recruiting

Other Dankook University trials

Trials by the same sponsor.

NCT03375528 — Matrix Metalloproteinases Expression in the Neointimal Hyperplasia Induced by Drug Eluting Stent (DES) Implantation · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03683485 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Dankook University
Last refreshed: 1 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03683485.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing